ZSH-2208
Product Specifications
CAS Number
2131803-75-1
SKU
C03646-5mg
Target
Immunology & Inflammation related
Applications
Immunology & Inflammation
Additionnal Information
ZSH‐2208 is a RARγ-selective retinoic acid analogue that exhibits potent anti-tumor effects in oesophageal squamous cell carcinoma (ESCC) . It inhibits ESCC tumour-repopulating cells (TRCs) by downregulating TNFAIP3, thereby suppressing proliferation and promoting apoptosis.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15350117 1 Vial
Lentiviral human H4C5 shRNA (UAS) - Lentiviral human H4C5 shRNA (UAS, iRFP) (25)
Ask
View Details MBS6315246-01 0.1 mL
LARS2, ID (LARS2, KIAA0028, Probable leucine-tRNA ligase, mitochondrial, Leucyl-tRNA synthetase) (MaxLight 550)
Ask
View Details 
MBS6315246-02 5x 0.1 mL
LARS2, ID (LARS2, KIAA0028, Probable leucine-tRNA ligase, mitochondrial, Leucyl-tRNA synthetase) (MaxLight 550)
Ask
View Details 
MBS1039845-01 0.02 mg (E-Coli)
Recombinant Aeromonas hydrophila subsp. hydrophila NADH-quinone oxidoreductase subunit B (nuoB)
Ask
View Details MBS1039845-02 0.1 mg (E-Coli)
Recombinant Aeromonas hydrophila subsp. hydrophila NADH-quinone oxidoreductase subunit B (nuoB)
Ask
View Details MBS1039845-03 0.02 mg (Yeast)
Recombinant Aeromonas hydrophila subsp. hydrophila NADH-quinone oxidoreductase subunit B (nuoB)
Ask
View Details